查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1547723

全球外泌體市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Exosomes Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2032年，全球外泌體市場需求將從2023年的1.6974億美元達到近2.2498億美元的市場規模，2024-2032年研究期間的複合年成長率為3.18%。

外泌體是指含有產生它們的細胞的蛋白質、RNA 和 DNA 的細胞外囊泡。外泌體療法是用於癌症早期檢測的新療法。從牛奶中提取的外泌體主要用於傳遞針對乳癌和肺癌的治療分子。外泌體具有作為藥物傳遞載體的巨大潛力，因為它們具有天然的物質運輸特性，例如高生物相容性和內在的長期循環。透過外泌體進行的細胞間通訊被認為參與了癌症、發炎和神經退化性疾病等多種疾病的發病機制。

市場動態

全球癌症發生率的上升，以及外泌體分離和分析程序的技術進步，是預測期內推動外泌體市場的主要因素。此外，外泌體在治療中的先進應用的增加以及對癌症早期診斷的日益重視，極大地促進了全球外泌體市場的成長。醫療保健支出的增加和與醫療保健相關的意識的增強對全球外泌體市場的成長產生了積極影響。此外，私人和公共機構不斷增加的腫瘤學研究和開發，加上主要參與者強大的管道產品，預計將在未來幾年為市場創造利潤豐厚的機會。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球外泌體市場的各個細分市場進行了包容性評估。外泌體產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

外泌體市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 試劑盒和試劑
  • 儀器儀表
  • 服務

按工作流程

  • 分離方法（超速離心、珠子免疫捕獲、沉澱、過濾等）
  • 下游分析（使用流式細胞儀進行細胞表面標記分析、使用印跡和 Elisa 進行蛋白質分析、使用 Ngs 和 PCR 進行 RNA 分析、使用質譜圖進行蛋白質體分析等）

按申請

  • 癌症
  • 神經退化性疾病
  • 心血管疾病
  • 傳染病
  • 其他

按最終用途

  • 製藥與生物技術公司
  • 醫院和診斷中心
  • 學術及研究機構

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲外泌體市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。外泌體市場的主要參與者包括 Danaher Corporation、Hologic Inc.、Fujifilm Holdings Corporation、Lonza、Miltenyi Biotec、Bio-Techne Corporation、QIAGEN、Thermo Fisher Scientific Inc.、Abcam Plc、RoosterBio Inc.。競爭格局，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：外泌體 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 依工作流程進行市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球外泌體市場分析：依產品分類

  • 概述（按產品）
  • 歷史和預測數據
  • 按產品分析
  • 試劑盒和試劑
  • 儀器儀表
  • 服務

第 6 章：全球外泌體市場分析：依工作流程

  • 按工作流程概述
  • 歷史和預測數據
  • 按工作流程分析
  • 分離方法（超速離心、珠子免疫捕獲、沉澱、過濾等）
  • 下游分析（使用流式細胞儀進行細胞表面標記分析、使用印跡和 Elisa 進行蛋白質分析、使用 Ngs 和 PCR 進行 RNA 分析、使用質譜圖進行蛋白質體分析等）

第 7 章：全球外泌體市場分析：依應用分類

  • 概述：按應用
  • 歷史和預測數據
  • 分析：按應用
  • 癌症
  • 神經退化性疾病
  • 心血管疾病
  • 傳染病
  • 其他

第 8 章：全球外泌體市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 製藥與生物技術公司
  • 醫院和診斷中心
  • 學術及研究機構

第 9 章：全球外泌體市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：外泌體公司的競爭格局

  • 外泌體市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Danaher Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Hologic Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Fujifilm Holdings Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Lonza
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Miltenyi Biotec
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio-Techne Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • QIAGEN
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Abcam Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • RoosterBio Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11213631

The global demand for Exosomes Market is presumed to reach the market size of nearly USD 224.98 Million by 2032 from USD 169.74 Million in 2023 with a CAGR of 3.18% under the study period 2024-2032.

Exosomes refer to an extracellular vesicle that contains protein, RNA, and DNA of the cells that produce them. Exosome therapy is the new treatment used in the early stage of cancer detection. Exosomes extracted from cow milk are majorly used to deliver therapeutic molecules against breast and lung cancers. Exosomes have huge potential to act like vehicles for drug delivery because they have natural material transportation properties such as high biocompatibility and intrinsic long-term circulation. Intercellular communication through exosomes supposed to be involved in the pathogenesis of a variety of disorders such as cancer, inflammatory and neurodegeneration diseases.

MARKET DYNAMICS

The rising prevalence of cancer cases across the globe, along with technological advancements in exosomes isolation and analytical procedures, are the major factors driving the exosomes market over the forecast period. Moreover, increasing advanced applications of exosomes in therapeutic and the rising emphasis on early diagnosis of cancer are highly contributing to the growth of the global exosomes market. The rising healthcare expenditure and growing awareness related to healthcare creates a positive impact on the growth of the exosomes market globally. Furthermore, increasing research and development in oncology by private and public institutions, coupled with strong pipeline products of key players, are expected to create a lucrative opportunity for the market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Exosomes. The growth and trends of Exosomes industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Exosomes market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Kits & Reagents
  • Instruments
  • Services

By Workflow

  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others)

By Application

  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

By End-Use

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Exosomes market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Exosomes market include Danaher Corporation, Hologic Inc., Fujifilm Holdings Corporation, Lonza, Miltenyi Biotec, Bio-Techne Corporation, QIAGEN, Thermo Fisher Scientific Inc., Abcam Plc, RoosterBio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EXOSOMES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EXOSOMES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Kits & Reagents Historic and Forecast Sales By Regions
  • 5.5. Instruments Historic and Forecast Sales By Regions
  • 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL EXOSOMES MARKET ANALYSIS BY WORKFLOW

  • 6.1. Overview By Workflow
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Workflow
  • 6.4. Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Historic and Forecast Sales By Regions
  • 6.5. Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Historic and Forecast Sales By Regions

7. GLOBAL EXOSOMES MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Cancer Historic and Forecast Sales By Regions
  • 7.5. Neurodegenerative Diseases Historic and Forecast Sales By Regions
  • 7.6. Cardiovascular Diseases Historic and Forecast Sales By Regions
  • 7.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL EXOSOMES MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-Use
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-Use
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Hospitals & Diagnostics Centers Historic and Forecast Sales By Regions
  • 8.6. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL EXOSOMES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EXOSOMES COMPANIES

  • 10.1. Exosomes Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF EXOSOMES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Danaher Corporation
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Hologic Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Fujifilm Holdings Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Lonza
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Miltenyi Biotec
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Bio-Techne Corporation
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. QIAGEN
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Thermo Fisher Scientific Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Abcam Plc
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. RoosterBio Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Kits & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By Workflow (USD MN)
  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Market Sales By Geography (USD MN)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Neurodegenerative Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Hospitals & Diagnostics Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Exosomes Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Exosomes Report
  • Market Research Process
  • Market Research Methodology
  • Global Exosomes Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Kits & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Workflow (USD MN)
  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Market Sales By Geography (USD MN)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Neurodegenerative Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Hospitals & Diagnostics Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.